Literature DB >> 23105815

Oxidative stress in Parkinson's disease.

Shashikant Nikam1, Padmaja Nikam, S K Ahaley, Ajit V Sontakke.   

Abstract

Oxidative stress contributes to the cascade, leading to dopamine cell degeneration in Parkinson's disease. However, oxidative stress is intimately linked to other components of the degenerative process, such as mitochondrial dysfunction, excitotoxicity, nitric oxide toxicity and inflammation. It is therefore difficult to determine whether oxidative stress leads to or is a consequence of, these events. Oxidative stress was assessed by estimating lipid peroxidation product in the form of thiobarbituric acid reactive substances, nitric oxide in the form of nitrite & nitrate. Enzymatic antioxidants in the form of superoxide dismutase, glutathione peroxidase, catalase, ceruloplasmin and non enzymatic antioxidant vitamins e.g. vitamin E and C in either serum or plasma or erythrocyte in 40 patients of Parkinson's disease in the age group 40-80 years. Trace elements e.g. copper, zinc and selenium were also estimated. Plasma thiobarbituric acid reactive substances and nitric oxide levels were Significantly high but superoxide dismutase, glutathione peroxidase, catalase, ceruloplasmin, vitamin-E, vitamin-C, copper, zinc and selenium levels were significantly low in Parkinson's disease when compared with control subjects. Present study showed that elevated oxidative stress may be playing a role in dopaminergic neuronal loss in substentia nigra pars compacta and involved in pathogenesis of the Parkinson's disease.

Entities:  

Keywords:  Antioxidants; Oxidative stress; Parkinson’s disease; Pathogenesis

Year:  2009        PMID: 23105815      PMCID: PMC3453463          DOI: 10.1007/s12291-009-0017-y

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

Review 1.  Molecular basis of the neurodegenerative disorders.

Authors:  J B Martin
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

Review 2.  Antioxidant therapy in ALS.

Authors:  E P Pioro
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

3.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

4.  Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method.

Authors:  N K Cortas; N W Wakid
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

Review 5.  Antioxidants, oxidative stress, and degenerative neurological disorders.

Authors:  R A Floyd
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

6.  Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes.

Authors:  R Benecke; P Strümper; H Weiss
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

Review 7.  Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.

Authors:  K A Jellinger
Journal:  Mol Chem Neuropathol       Date:  1991-06

8.  Vitamin E protects nerve cells from amyloid beta protein toxicity.

Authors:  C Behl; J Davis; G M Cole; D Schubert
Journal:  Biochem Biophys Res Commun       Date:  1992-07-31       Impact factor: 3.575

Review 9.  Apoptotic death in an in vitro model of neuronal oxidative stress.

Authors:  R R Ratan; J M Baraban
Journal:  Clin Exp Pharmacol Physiol       Date:  1995-04       Impact factor: 2.557

  9 in total
  30 in total

1.  Neuroprotective effects of hydroalcoholic extract of Ocimum sanctum against H2O2 induced neuronal cell damage in SH-SY5Y cells via its antioxidative defence mechanism.

Authors:  M P Venuprasad; Kandikattu Hemanth Kumar; Farhath Khanum
Journal:  Neurochem Res       Date:  2013-08-31       Impact factor: 3.996

2.  Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.

Authors:  Peijian Yue; Lin Gao; Xuejing Wang; Xuebing Ding; Junfang Teng
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

3.  Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease.

Authors:  Kasthuri Bai Magalingam; Ammu Radhakrishnan; Premdass Ramdas; Nagaraja Haleagrahara
Journal:  J Mol Neurosci       Date:  2014-08-17       Impact factor: 3.444

4.  Cypermethrin alters the status of oxidative stress in the peripheral blood: relevance to Parkinsonism.

Authors:  Pratibha Tripathi; Ashish Singh; Sonal Agrawal; Om Prakash; Mahendra Pratap Singh
Journal:  J Physiol Biochem       Date:  2014-10-01       Impact factor: 4.158

5.  PARK2 and PARK7 Gene Polymorphisms as Risk Factors Associated with Serum Element Concentrations and Clinical Symptoms of Parkinson's Disease.

Authors:  Jaya Sanyal; Athira Anirudhan; Tapas Kumar Banerjee; Gautam Guha; Ram Murugesan; S S J Shiek Ahmed; Vadlamudi Raghavendra Rao
Journal:  Cell Mol Neurobiol       Date:  2019-09-11       Impact factor: 5.046

6.  Evaluation of levodopa and carbidopa antioxidant activity in normal human lymphocytes in vitro: implication for oxidative stress in Parkinson's disease.

Authors:  Monica Colamartino; Massimo Santoro; Guglielmo Duranti; Stefania Sabatini; Roberta Ceci; Antonella Testa; Luca Padua; Renata Cozzi
Journal:  Neurotox Res       Date:  2014-10-30       Impact factor: 3.911

7.  Oxidative and nitrosative stress in serum of patients with Parkinson's disease.

Authors:  Hikmet Can Çubukçu; Mustafa Yurtdaş; Zahide Esra Durak; Bilal Aytaç; Hafize Nalan Güneş; Burcu Gökçe Çokal; Tahir Kurtuluş Yoldaş; İlker Durak
Journal:  Neurol Sci       Date:  2016-07-16       Impact factor: 3.307

8.  Protective effects of quercetin glycosides, rutin, and isoquercetrin against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in rat pheochromocytoma (PC-12) cells.

Authors:  Kasthuri Bai Magalingam; Ammu Radhakrishnan; Nagaraja Haleagrahara
Journal:  Int J Immunopathol Pharmacol       Date:  2015-11-05       Impact factor: 3.219

Review 9.  Vanadium inhalation in a mouse model for the understanding of air-suspended particle systemic repercussion.

Authors:  T I Fortoul; V Rodriguez-Lara; A Gonzalez-Villalva; M Rojas-Lemus; G Cano-Gutierrez; M Ustarroz-Cano; L Colin-Barenque; L F Montaño; I García-Pelez; P Bizarro-Nevares; N Lopez-Valdez; C I Falcon-Rodriguez; R S Jimenez-Martínez; M L Ruiz-Guerrero; L S López-Zepeda; A Morales-Rivero; A Muñiz-Rivera-Cambas
Journal:  J Biomed Biotechnol       Date:  2011-05-22

10.  Redox processes in neurodegenerative disease involving reactive oxygen species.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.